Without actual evidence that the test matters for patient health, it’s a basic research project and a toy for biohackers — both of which are fantastic but neither of which make sense as VC-funded startups. They should be small businesses or nonprofits!
-
-
my understanding (to be clear this is not my area of expertise) is that the tiny volumes of blood used inevitably lead to wildly variable results, especially if you want to run multiple tests from a single draw
-
I doubt that there's literally no info in that blood. Maybe one needs to rethink all the tests. Instead of testing one compound, make a model that predicts things using all the available info and a big, sophisticated ML model. BTW, would I look good in a black turtleneck?
- 7 more replies
New conversation -
-
-
Someone should start a "Like Theranos, except it actually works" company.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.